NDC 58160-827 – Menveo
Neisseria Meningitidis Group A Capsular Oligosaccharide Diphtheria Crm197 Protein Conjugate Antigen 10 ug/.5mL; Neisseria Meningitidis Group C Capsular… · Injection, Solution · Intramuscular
Product NDC58160-827
Product details
- Brand name
- Menveo
- Generic name
- Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine
- Labeler
- GlaxoSmithKline Biologicals SA
- Dosage form
- Injection, Solution
- Route
- Intramuscular
- Marketing category
- BLA · BLA125300
- Marketed since
- December 9, 2022
- Listing expires
- December 31, 2027
- Pharmacologic class
- Inactivated Meningococcal Vaccine; Inactivated Meningococcal Vaccine; Inactivated Meningococcal Vaccine; Inactivated Meningococcal Vaccine
Active ingredients
- Neisseria Meningitidis Group A Capsular Oligosaccharide Diphtheria Crm197 Protein Conjugate Antigen 10 ug/.5mL
- Neisseria Meningitidis Group C Capsular Oligosaccharide Diphtheria Crm197 Protein Conjugate Antigen 5 ug/.5mL
- Neisseria Meningitidis Group W-135 Capsular Oligosaccharide Diphtheria Crm197 Protein Conjugate Antigen 5 ug/.5mL
- Neisseria Meningitidis Group Y Capsular Oligosaccharide Diphtheria Crm197 Protein Conjugate Antigen 5 ug/.5mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 58160-827-30 | 10 VIAL in 1 CARTON (58160-827-30) / .5 mL in 1 VIAL (58160-827-03) | Dec 9, 2022 |
Other Menveo products
- 58160-955 · Kit · GlaxoSmithKline Biologicals SA